RxDoctor Payments Data

Hilary Ma, MD

Hematology & Oncology · Houston, TXNPI 1437361623

Payments from drug & device makers

$670,722in general payments, 2019–2025

Across 457 payments — averaging $1467.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$671K
  • Pfizer$133
  • Amgen$37
  • Johnson & Johnson$23
  • Gilead$12

What the payments were for

  • Food & beverage$6029%
  • Education$14571%

General payments by program year

19
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bayer441$670,517
Pfizer12$133
Amgen2$37
Johnson & Johnson1$23
Gilead1$12

How this compares

$670,722 in reported general payments places this provider in the 85th percentile of 838 hematology & oncology providers in Texas.

See all hematology & oncology providers in Texas

Medicare billing

Part B allowed, 2024
$8,202
Medicare patients
48
Services billed
64

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Anastrozole25$427

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →